MIGUEL ÁNGEL CALLEJA HERNÁNDEZ-rekin lankidetzan egindako argitalpenak (5)

2023

  1. Clinical Outcomes of First-line Therapies for Advanced Non-Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020

    American journal of clinical oncology, Vol. 46, Núm. 10, pp. 433-438

2020

  1. Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

    Journal of Infection and Public Health, Vol. 13, Núm. 4, pp. 558-563

2019

  1. Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis

    International Journal of Infectious Diseases, Vol. 85, pp. 80-87

2017

  1. ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

    Surgical Oncology, Vol. 26, Núm. 4, pp. 473-482

2016

  1. Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer

    Cancer Medicine, Vol. 5, Núm. 9, pp. 2190-2197